Saved content diff
https://www.mhlw.go.jp/stf/newpage_37021.html
Changed blocks
5
Added lines
6
Removed lines
7
Before
This page announces administrative actions taken against Sawai Pharmaceutical's Kyushu plant regarding improper quality testing methods for the medication Teprenone Capsule 50mg. The company used different testing procedures than those approved, including replacing capsules before conducting dissolution tests. Osaka and Fukuoka prefectures issued business improvement orders, and the Ministry of Health, Labour and Welfare ordered a change in the responsible person for manufacturing and sales. The incident poses minimal risk to drug efficacy and safety, with no adverse health reports.
After
-
Before
言語切替 日本語
After
Language Japanese
Before
日本語
After
Japanese
Before
言語切替 日本語
After
Language Japanese
Before
日本語
After
Japanese
Before
厚生労働省広報基本指針
Previous screenshot
Latest screenshot
